Showing results (601-610 of 831) with videos related to

Sort By:
Pageof 84
Cancers|July 13, 2024
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number AlterationsJ Erin Wiedmeier-Nutor, Chantal E McCabe, Daniel R O'Brien, et al.
Leukemia & Lymphoma|April 25, 2019
Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practicePaul J Hampel, Wei Ding, Timothy G Call, et al.
Blood|August 15, 2022
Progression and survival of MBL: a screening study of 10 139 individualsSusan L Slager, Sameer A Parikh, Sara J Achenbach, et al.
Cancer Genetics|March 12, 2014
Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participantsCathy C Laurie, Cecelia A Laurie, Stephanie A Smoley, et al.
American Journal of Hematology|October 10, 2019
Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitorsIman Abou Dalle, Hagop M Kantarjian, Nicholas J Short, et al.
Cancer|August 28, 2003
Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phaseSusan O'Brien, Francis Giles, Moshe Talpaz, et al.
Blood|January 10, 2012
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experienceHagop Kantarjian, Susan O'Brien, Elias Jabbour, et al.
Clinical Lymphoma & Myeloma|December 16, 2005
T-cell prolymphocytic leukemia: a single-institution experienceFarhad Ravandi, Susan O'Brien, Dan Jones, et al.
International Journal of Hematology|February 22, 2018
Characteristics and outcome of chronic myeloid leukemia patients with E255K/V BCR-ABL kinase domain mutationsKiran Naqvi, Jorge E Cortes, Raja Luthra, et al.
British Journal of Haematology|July 29, 2014
Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemiaChristopher B Benton, Deborah A Thomas, Hui Yang, et al.
Pageof 84